Clinical Trial Update: Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term administration of human albumin in people with decompensated cirrhosis and ascites has completed and results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Decompensated Cirrhosis

Drugs mentioned

• Human Albumin

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Decompensated Cirrhosis and Ascites | Phase 3 | Status: COMPLETED | Results posted: 2025-06-06